Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05380648
Other study ID # 13/47/472
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 8, 2018
Est. completion date July 14, 2023

Study information

Verified date December 2023
Source Universiteit Antwerpen
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Osteoarthritis (OA) is the main cause of pain and disability in elderly. For knee OA, a total knee replacement (TKR) is an effective surgical treatment, and the majority of patients report substantial pain relief and functional improvement following surgery. However, 20-40% of patients undergoing TKR are dissatisfied with postsurgical outcome. Even after revision, some patients keep complaining of persisting pain. In this study, the investigators will examine putative prognostic factors on the basis of the biopsychosocial model. Besides several psychological factors (measured with questionnaires), the investigators will assess structural impairments (such as radiographic severity of OA), functional impairments (muscle weakness and proprioceptive deficits), anesthetic procedures, immediate postoperative pain management, metabolic factors (body composition and hemoglobin A1c), inflammatory factors (C-Reactive Protein) and the investigators also will examine the role of altered central pain processing (CPP) (primary and secondary mechanical hyperalgesia, mechanical temporal summation, thermal primary and secondary hyperalgesia, endogenous pain modulation). With a longitudinal study design, this study will explore which factors are predictive of poor outcome in knee OA patients after TKR. Moreover, the interrelationship between CPP, structural, functional, metabolic, inflammatory and psychological factors, and the clinical expression of knee OA (pain, symptoms, physical performance and quality of life) will be investigated. Further research on the role of the aforementioned putative prognostic factors on postsurgical outcome could contribute to better management of these patients, since these factors may be particularly important for patient-tailored treatment.


Recruitment information / eligibility

Status Completed
Enrollment 223
Est. completion date July 14, 2023
Est. primary completion date July 14, 2023
Accepts healthy volunteers No
Gender All
Age group 40 Years and older
Eligibility Inclusion Criteria: - Knee OA patients >40 years awaiting TKR surgery. Both men and women of all ethnical backgrounds are included. Exclusion Criteria: - Patients with diagnosis of neurological/ systemic diseases, possibly impacting pain - Patients who are not capable of understanding and speaking Dutch - Revision surgery

Study Design


Intervention

Procedure:
Total knee arthroplasty
Total knee arthroplasty surgery will be performed by different orthopedist.

Locations

Country Name City State
Belgium University of Antwerp Antwerp

Sponsors (1)

Lead Sponsor Collaborator
Universiteit Antwerpen

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain intensity The subscale 'Pain' of the Knee injury and Osteoarthritis Outcome Score (KOOS) will be used as primary outcome measure. Minimum score is 0, maximum score is 36. Scores are always transformed to a 0-100 scale. The higher the score, the higher the pain intensity. Change from baseline pain intensity at 3 months postoperative
Primary Pain intensity The subscale 'Pain' of the Knee injury and Osteoarthritis Outcome Score (KOOS) will be used as primary outcome measure. Minimum score is 0, maximum score is 36. Scores are always transformed to a 0-100 scale. The higher the score, the higher the pain intensity. Change from baseline pain intensity at 1 year postoperative
Primary Pain intensity The subscale 'Pain' of the Knee injury and Osteoarthritis Outcome Score (KOOS) will be used as primary outcome measure. Minimum score is 0, maximum score is 36. Scores are always transformed to a 0-100 scale. The higher the score, the higher the pain intensity. Change from 3 months postoperative at 1 year postoperative
Primary Pain intensity The subscale 'Pain' of the Knee injury and Osteoarthritis Outcome Score (KOOS) will be used as primary outcome measure. Minimum score is 0, maximum score is 36. Scores are always transformed to a 0-100 scale. The higher the score, the higher the pain intensity. Baseline (preoperative)
Primary Pain intensity The subscale 'Pain' of the Knee injury and Osteoarthritis Outcome Score (KOOS) will be used as primary outcome measure. Minimum score is 0, maximum score is 36. Scores are always transformed to a 0-100 scale. The higher the score, the higher the pain intensity. 3 months postoperative
Primary Pain intensity The subscale 'Pain' of the Knee injury and Osteoarthritis Outcome Score (KOOS) will be used as primary outcome measure. Minimum score is 0, maximum score is 36. Scores are always transformed to a 0-100 scale. The higher the score, the higher the pain intensity. 1 year postoperative
Secondary Central pain processing: mechanical local and widespread hyperalgesia allodynia Measured with quantitative sensory testing (QST): mechanical pain pressure threshold measured with digital algometer at the medial knee joint line, lateral knee joint line and m. Tibialis anterior of affected leg, m. extensor carpi radialis of non-dominant arm and forehead. Change from baseline (preoperative) to 3 months postoperative
Secondary Central pain processing: mechanical local and widespread hyperalgesia allodynia Measured with quantitative sensory testing (QST): mechanical pain pressure threshold measured with digital algometer at the medial knee joint line, lateral knee joint line and m. Tibialis anterior of affected leg, m. extensor carpi radialis of non-dominant arm and forehead. Change from baseline (preoperative) to 1 year postoperative
Secondary Central pain processing: mechanical local and widespread hyperalgesia allodynia Measured with quantitative sensory testing (QST): mechanical pain pressure threshold measured with digital algometer at the medial knee joint line, lateral knee joint line and m. Tibialis anterior of affected leg, m. extensor carpi radialis of non-dominant arm and forehead. Change from 3 months postoperative to 1 year postoperative
Secondary Central pain processing: mechanical local and widespread hyperalgesia allodynia Measured with quantitative sensory testing (QST): mechanical pain pressure threshold measured with digital algometer at the medial knee joint line, lateral knee joint line and m. Tibialis anterior of affected leg, m. extensor carpi radialis of non-dominant arm and forehead. Baseline (preoperative)
Secondary Central pain processing: mechanical local and widespread hyperalgesia allodynia Measured with quantitative sensory testing (QST): mechanical pain pressure threshold measured with digital algometer at the medial knee joint line, lateral knee joint line and m. Tibialis anterior of affected leg, m. extensor carpi radialis of non-dominant arm and forehead. 3 months postoperative
Secondary Central pain processing: mechanical local and widespread hyperalgesia allodynia Measured with quantitative sensory testing (QST): mechanical pain pressure threshold measured with digital algometer at the medial knee joint line, lateral knee joint line and m. Tibialis anterior of affected leg, m. extensor carpi radialis of non-dominant arm and forehead. 1 year postoperative
Secondary Central pain processing: bottom-up sensitization Measured with quantitative sensory testing (QST): temporal summation measured with a 60g Von Frey monofilament at the medial knee and lateral knee of affected leg, dorsal wrist of affected side Change from baseline (preoperative) to 3 months postoperative
Secondary Central pain processing: bottom-up sensitization Measured with quantitative sensory testing (QST): temporal summation measured with a 60g Von Frey monofilament at the medial knee and lateral knee of affected leg, dorsal wrist of affected side Change from baseline (preoperative) to 1 year postoperative
Secondary Central pain processing: bottom-up sensitization Measured with quantitative sensory testing (QST): temporal summation measured with a 60g Von Frey monofilament at the medial knee and lateral knee of affected leg, dorsal wrist of affected side Change from 3 months postoperative to 1 year postoperative
Secondary Central pain processing: bottom-up sensitization Measured with quantitative sensory testing (QST): temporal summation measured with a 60g Von Frey monofilament at the medial knee and lateral knee of affected leg, dorsal wrist of affected side Baseline (preoperative)
Secondary Central pain processing: bottom-up sensitization Measured with quantitative sensory testing (QST): temporal summation measured with a 60g Von Frey monofilament at the medial knee and lateral knee of affected leg, dorsal wrist of affected side 3 months postoperative
Secondary Central pain processing: bottom-up sensitization Measured with quantitative sensory testing (QST): temporal summation measured with a 60g Von Frey monofilament at the medial knee and lateral knee of affected leg, dorsal wrist of affected side 1 year postoperative
Secondary Central pain processing: Thermal hyperalgesia Measured with quantitative sensory testing (QST): thermal pain sensitivity measured with thermal rollers (Rolltemp II somedic senselab) at the medial knee and lateral knee of affected leg and m. extensor carpi radialis of non-dominant arm. Change from baseline (preoperative) to 3 months postoperative
Secondary Central pain processing: Thermal hyperalgesia Measured with quantitative sensory testing (QST): thermal pain sensitivity measured with thermal rollers (Rolltemp II somedic senselab) at the medial knee and lateral knee of affected leg and m. extensor carpi radialis of non-dominant arm. Change from baseline (preoperative) to 1 year postoperative
Secondary Central pain processing: Thermal hyperalgesia Measured with quantitative sensory testing (QST): thermal pain sensitivity measured with thermal rollers (Rolltemp II somedic senselab) at the medial knee and lateral knee of affected leg and m. extensor carpi radialis of non-dominant arm. Change from 3 months postoperative to 1 year postoperative
Secondary Central pain processing: Thermal hyperalgesia Measured with quantitative sensory testing (QST): thermal pain sensitivity measured with thermal rollers (Rolltemp II somedic senselab) at the medial knee and lateral knee of affected leg and m. extensor carpi radialis of non-dominant arm. Baseline (preoperative)
Secondary Central pain processing: Thermal hyperalgesia Measured with quantitative sensory testing (QST): thermal pain sensitivity measured with thermal rollers (Rolltemp II somedic senselab) at the medial knee and lateral knee of affected leg and m. extensor carpi radialis of non-dominant arm. 3 months postoperative
Secondary Central pain processing: Thermal hyperalgesia Measured with quantitative sensory testing (QST): thermal pain sensitivity measured with thermal rollers (Rolltemp II somedic senselab) at the medial knee and lateral knee of affected leg and m. extensor carpi radialis of non-dominant arm. 1 year postoperative
Secondary Central pain processing: dysfunctional endogenous pain analgesia Measured with quantitative sensory testing (QST): conditioned pain modulation measured Medoc at both wrists Change from baseline (preoperative) to 3 months postoperative
Secondary Central pain processing: dysfunctional endogenous pain analgesia Measured with quantitative sensory testing (QST): conditioned pain modulation measured Medoc at both wrists Change from baseline (preoperative) to 1 year postoperative
Secondary Central pain processing: dysfunctional endogenous pain analgesia Measured with quantitative sensory testing (QST): conditioned pain modulation measured Medoc at both wrists Change from 3 months postoperative to 1 year postoperative
Secondary Central pain processing: dysfunctional endogenous pain analgesia Measured with quantitative sensory testing (QST): conditioned pain modulation measured Medoc at both wrists Baseline (preoperative)
Secondary Central pain processing: dysfunctional endogenous pain analgesia Measured with quantitative sensory testing (QST): conditioned pain modulation measured Medoc at both wrists 3 months postoperative
Secondary Central pain processing: dysfunctional endogenous pain analgesia Measured with quantitative sensory testing (QST): conditioned pain modulation measured Medoc at both wrists 1 year postoperative
Secondary Central pain processing: somatic and emotional symptoms Questionnaire: the Central sensitization Inventory (CSI). Minimum score is 0, maximum score is 100. The higher the score, the higher the chance for the presence of central sensitization. Change from baseline (preoperative) to 3 months postoperative
Secondary Central pain processing: somatic and emotional symptoms Questionnaire: the Central sensitization Inventory (CSI). Minimum score is 0, maximum score is 100. The higher the score, the higher the chance for the presence of central sensitization. Change from baseline (preoperative) to 1 year postoperative
Secondary Central pain processing: somatic and emotional symptoms Questionnaire: the Central sensitization Inventory (CSI). Minimum score is 0, maximum score is 100. The higher the score, the higher the chance for the presence of central sensitization. Change from 3 months postoperative to 1 year postoperative
Secondary Central pain processing: somatic and emotional symptoms Questionnaire: the Central sensitization Inventory (CSI). Minimum score is 0, maximum score is 100. The higher the score, the higher the chance for the presence of central sensitization. Baseline (preoperative)
Secondary Central pain processing: somatic and emotional symptoms Questionnaire: the Central sensitization Inventory (CSI). Minimum score is 0, maximum score is 100. The higher the score, the higher the chance for the presence of central sensitization. 3 months postoperative
Secondary Central pain processing: somatic and emotional symptoms Questionnaire: the Central sensitization Inventory (CSI). Minimum score is 0, maximum score is 100. The higher the score, the higher the chance for the presence of central sensitization. 1 year postoperative
Secondary Central pain processing: areas of pain Body chart: Expanded distribution of Pain (EDP). The more pain locations, the more chance for the presence of central sensitization Change from baseline (preoperative) to 3 months postoperative
Secondary Central pain processing: areas of pain Body chart: Expanded distribution of Pain (EDP). The more pain locations, the more chance for the presence of central sensitization Change from baseline (preoperative) to 1 year postoperative
Secondary Central pain processing: areas of pain Body chart: Expanded distribution of Pain (EDP). The more pain locations, the more chance for the presence of central sensitization Change from 3 months postoperative to 1 year postoperative
Secondary Central pain processing: areas of pain Body chart: Expanded distribution of Pain (EDP). The more pain locations, the more chance for the presence of central sensitization Baseline (preoperative)
Secondary Central pain processing: areas of pain Body chart: Expanded distribution of Pain (EDP). The more pain locations, the more chance for the presence of central sensitization 3 months postoperative
Secondary Central pain processing: areas of pain Body chart: Expanded distribution of Pain (EDP). The more pain locations, the more chance for the presence of central sensitization 1 year postoperative
Secondary Psychosocial factors: pain catastrophizing Measured with Pain Catastrophizing Scale (PCS). Minimum score is 0, maximum score is 52. The higher the score, the higher the pain catastrophizing. Change from baseline (preoperative) to 3 months postoperative
Secondary Psychosocial factors: pain catastrophizing Measured with Pain Catastrophizing Scale (PCS). Minimum score is 0, maximum score is 52. The higher the score, the higher the pain catastrophizing. Change from baseline (preoperative) to 1 year postoperative
Secondary Psychosocial factors: pain catastrophizing Measured with Pain Catastrophizing Scale (PCS). Minimum score is 0, maximum score is 52. The higher the score, the higher the pain catastrophizing. Change from 3 months postoperative to 1 year postoperative
Secondary Psychosocial factors: pain catastrophizing Measured with Pain Catastrophizing Scale (PCS). Minimum score is 0, maximum score is 52. The higher the score, the higher the pain catastrophizing. Baseline (preoperative)
Secondary Psychosocial factors: pain catastrophizing Measured with Pain Catastrophizing Scale (PCS). Minimum score is 0, maximum score is 52. The higher the score, the higher the pain catastrophizing. 3 months postoperative
Secondary Psychosocial factors: pain catastrophizing Measured with Pain Catastrophizing Scale (PCS). Minimum score is 0, maximum score is 52. The higher the score, the higher the pain catastrophizing. 1 year postoperative
Secondary Psychosocial factors: illness perceptions Illness perception questionnaire-revised (IPQ-R)
Identity dimension:
yes = 1; no = 0 min score= 0, max score= 18
Other dimensions:
min score= 38, max score= 190 strongly disagree =1, disagree =2, neither agree or disagree = 3, agree = 4, strongly agree = 5
Causal dimension:
strongly disagree =1, disagree =2, neither agree or disagree = 3, agree = 4, strongly agree = 5 min score= 18, max score= 90
High scores on the identity, timeline, consequences, and cyclical dimensions represent strongly held beliefs about the number of symptoms attributed to the illness, the chronicity of the condition, the negative consequences of the illness, and the cyclical nature of the condition.
High scores on the personal control, treatment control and coherence dimensions, represent positive beliefs about the controllability of the illness and a personal understanding of the condition.
Change from baseline (preoperative) to 3 months postoperative
Secondary Psychosocial factors: illness perceptions Illness perception questionnaire-revised (IPQ-R)
Identity dimension:
yes = 1; no = 0 min score= 0, max score= 18
Other dimensions:
min score= 38, max score= 190 strongly disagree =1, disagree =2, neither agree or disagree = 3, agree = 4, strongly agree = 5
Causal dimension:
strongly disagree =1, disagree =2, neither agree or disagree = 3, agree = 4, strongly agree = 5 min score= 18, max score= 90
High scores on the identity, timeline, consequences, and cyclical dimensions represent strongly held beliefs about the number of symptoms attributed to the illness, the chronicity of the condition, the negative consequences of the illness, and the cyclical nature of the condition.
High scores on the personal control, treatment control and coherence dimensions, represent positive beliefs about the controllability of the illness and a personal understanding of the condition.
Change from baseline (preoperative) to 1 year postoperative
Secondary Psychosocial factors: illness perceptions Illness perception questionnaire-revised (IPQ-R)
Identity dimension:
yes = 1; no = 0 min score= 0, max score= 18
Other dimensions:
min score= 38, max score= 190 strongly disagree =1, disagree =2, neither agree or disagree = 3, agree = 4, strongly agree = 5
Causal dimension:
strongly disagree =1, disagree =2, neither agree or disagree = 3, agree = 4, strongly agree = 5 min score= 18, max score= 90
High scores on the identity, timeline, consequences, and cyclical dimensions represent strongly held beliefs about the number of symptoms attributed to the illness, the chronicity of the condition, the negative consequences of the illness, and the cyclical nature of the condition.
High scores on the personal control, treatment control and coherence dimensions, represent positive beliefs about the controllability of the illness and a personal understanding of the condition.
Change from 3 months postoperative to 1 year postoperative
Secondary Psychosocial factors: illness perceptions Illness perception questionnaire-revised (IPQ-R)
Identity dimension:
yes = 1; no = 0 min score= 0, max score= 18
Other dimensions:
min score= 38, max score= 190 strongly disagree =1, disagree =2, neither agree or disagree = 3, agree = 4, strongly agree = 5
Causal dimension:
strongly disagree =1, disagree =2, neither agree or disagree = 3, agree = 4, strongly agree = 5 min score= 18, max score= 90
High scores on the identity, timeline, consequences, and cyclical dimensions represent strongly held beliefs about the number of symptoms attributed to the illness, the chronicity of the condition, the negative consequences of the illness, and the cyclical nature of the condition.
High scores on the personal control, treatment control and coherence dimensions, represent positive beliefs about the controllability of the illness and a personal understanding of the condition.
Baseline (preoperative)
Secondary Psychosocial factors: illness perceptions Illness perception questionnaire-revised (IPQ-R)
Identity dimension:
yes = 1; no = 0 min score= 0, max score= 18
Other dimensions:
min score= 38, max score= 190 strongly disagree =1, disagree =2, neither agree or disagree = 3, agree = 4, strongly agree = 5
Causal dimension:
strongly disagree =1, disagree =2, neither agree or disagree = 3, agree = 4, strongly agree = 5 min score= 18, max score= 90
High scores on the identity, timeline, consequences, and cyclical dimensions represent strongly held beliefs about the number of symptoms attributed to the illness, the chronicity of the condition, the negative consequences of the illness, and the cyclical nature of the condition.
High scores on the personal control, treatment control and coherence dimensions, represent positive beliefs about the controllability of the illness and a personal understanding of the condition.
3 months postoperative
Secondary Psychosocial factors: illness perceptions Illness perception questionnaire-revised (IPQ-R)
Identity dimension:
yes = 1; no = 0 min score= 0, max score= 18
Other dimensions:
min score= 38, max score= 190 strongly disagree =1, disagree =2, neither agree or disagree = 3, agree = 4, strongly agree = 5
Causal dimension:
strongly disagree =1, disagree =2, neither agree or disagree = 3, agree = 4, strongly agree = 5 min score= 18, max score= 90
High scores on the identity, timeline, consequences, and cyclical dimensions represent strongly held beliefs about the number of symptoms attributed to the illness, the chronicity of the condition, the negative consequences of the illness, and the cyclical nature of the condition.
High scores on the personal control, treatment control and coherence dimensions, represent positive beliefs about the controllability of the illness and a personal understanding of the condition.
1 year postoperative
Secondary Psychosocial factors: anxiety Measured with Hospital Anxiety and Depression Scale (HADS), subscale anxiety. Minimum score is 0, maximum score is 21. The higher the score, the higher the anxiety. Change from baseline (preoperative) to 3 months postoperative
Secondary Psychosocial factors: anxiety Measured with Hospital Anxiety and Depression Scale (HADS), subscale anxiety. Minimum score is 0, maximum score is 21. The higher the score, the higher the anxiety. Change from baseline (preoperative) to 1 year postoperative
Secondary Psychosocial factors: anxiety Measured with Hospital Anxiety and Depression Scale (HADS), subscale anxiety. Minimum score is 0, maximum score is 21. The higher the score, the higher the anxiety. Change from 3 months postoperative to 1 year postoperative
Secondary Psychosocial factors: anxiety Measured with Hospital Anxiety and Depression Scale (HADS), subscale anxiety. Minimum score is 0, maximum score is 21. The higher the score, the higher the anxiety. Baseline (preoperative)
Secondary Psychosocial factors: anxiety Measured with Hospital Anxiety and Depression Scale (HADS), subscale anxiety. Minimum score is 0, maximum score is 21. The higher the score, the higher the anxiety. 3 months postoperative
Secondary Psychosocial factors: anxiety Measured with Hospital Anxiety and Depression Scale (HADS), subscale anxiety. Minimum score is 0, maximum score is 21. The higher the score, the higher the anxiety. 1 year postoperative
Secondary Psychosocial factors: depression Measured with Hospital Anxiety and Depression Scale (HADS), subscale depression. Minimum score is 0, maximum score is 21. The higher the score, the higher the depression. Change from baseline (preoperative) to 3 months postoperative
Secondary Psychosocial factors: depression Measured with Hospital Anxiety and Depression Scale (HADS), subscale depression. Minimum score is 0, maximum score is 21. The higher the score, the higher the depression. Change from baseline (preoperative) to 1 year postoperative
Secondary Psychosocial factors: depression Measured with Hospital Anxiety and Depression Scale (HADS), subscale depression. Minimum score is 0, maximum score is 21. The higher the score, the higher the depression. Change from 3 months postoperative to 1 year postoperative
Secondary Psychosocial factors: depression Measured with Hospital Anxiety and Depression Scale (HADS), subscale depression. Minimum score is 0, maximum score is 21. The higher the score, the higher the depression. Baseline (preoperative)
Secondary Psychosocial factors: depression Measured with Hospital Anxiety and Depression Scale (HADS), subscale depression. Minimum score is 0, maximum score is 21. The higher the score, the higher the depression. 3 months postoperative
Secondary Psychosocial factors: depression Measured with Hospital Anxiety and Depression Scale (HADS), subscale depression. Minimum score is 0, maximum score is 21. The higher the score, the higher the depression. 1 year postoperative
Secondary Functional factors: Maximal voluntary muscle strength m. Hamstrings Strength m. Hamstrings of both legs, measured with Biodex System 4 pro - dynamometer Change from baseline (preoperative) to 3 months postoperative
Secondary Functional factors: Maximal voluntary muscle strength m. Hamstrings Strength m. Hamstrings of both legs, measured with Biodex System 4 pro - dynamometer Change from baseline (preoperative) to 1 year postoperative
Secondary Functional factors: Maximal voluntary muscle strength m. Hamstrings Strength m. Hamstrings of both legs, measured with Biodex System 4 pro - dynamometer Change from 3 months postoperative to 1 year postoperative
Secondary Functional factors: Maximal voluntary muscle strength m. Hamstrings Strength m. Hamstrings of both legs, measured with Biodex System 4 pro - dynamometer 3 months postoperative
Secondary Functional factors: Maximal voluntary muscle strength m. Hamstrings Strength m. Hamstrings of both legs, measured with Biodex System 4 pro - dynamometer Baseline (preoperative)
Secondary Functional factors: Maximal voluntary muscle strength m. Hamstrings Strength m. Hamstrings of both legs, measured with Biodex System 4 pro - dynamometer 1 year postoperative
Secondary Functional factors: Maximal voluntary muscle strength m. Quadriceps Strength m. Quadriceps of both legs, measured with Biodex System 4 pro - dynamometer Change from baseline (preoperative) to 3 months postoperative
Secondary Functional factors: Maximal voluntary muscle strength m. Quadriceps Strength m. Quadriceps of both legs, measured with Biodex System 4 pro - dynamometer Change from baseline (preoperative) to 1 year postoperative
Secondary Functional factors: Maximal voluntary muscle strength m. Quadriceps Strength m. Quadriceps of both legs, measured with Biodex System 4 pro - dynamometer Change from 3 months postoperative to 1 year postoperative
Secondary Functional factors: Maximal voluntary muscle strength m. Quadriceps Strength m. Quadriceps of both legs, measured with Biodex System 4 pro - dynamometer Baseline (preoperative)
Secondary Functional factors: Maximal voluntary muscle strength m. Quadriceps Strength m. Quadriceps of both legs, measured with Biodex System 4 pro - dynamometer 3 months postoperative
Secondary Functional factors: Maximal voluntary muscle strength m. Quadriceps Strength m. Quadriceps of both legs, measured with Biodex System 4 pro - dynamometer 1 year postoperative
Secondary Functional factors: proprioceptive accuracy Proprioception of the knee of both legs, measured with inclinometer Change from baseline (preoperative) to 3 months postoperative
Secondary Functional factors: proprioceptive accuracy Proprioception of the knee of both legs, measured with inclinometer Change from baseline (preoperative) to 1 year postoperative
Secondary Functional factors: proprioceptive accuracy Proprioception of the knee of both legs, measured with inclinometer Change from 3 months postoperative to 1 year postoperative
Secondary Functional factors: proprioceptive accuracy Proprioception of the knee of both legs, measured with inclinometer Baseline (preoperative)
Secondary Functional factors: proprioceptive accuracy Proprioception of the knee of both legs, measured with inclinometer 3 months postoperative
Secondary Functional factors: proprioceptive accuracy Proprioception of the knee of both legs, measured with inclinometer 1 year postoperative
Secondary Functional factors: leg strength and endurance Measured with 30 seconds Timed Chair-Stand-Test Change from baseline (preoperative) to 3 months postoperative
Secondary Functional factors: leg strength and endurance Measured with 30 seconds Timed Chair-Stand-Test Change from baseline (preoperative) to 1 year postoperative
Secondary Functional factors: leg strength and endurance Measured with 30 seconds Timed Chair-Stand-Test Change from 3 months postoperative to 1 year postoperative
Secondary Functional factors: leg strength and endurance Measured with 30 seconds Timed Chair-Stand-Test Baseline (preoperative)
Secondary Functional factors: leg strength and endurance Measured with 30 seconds Timed Chair-Stand-Test 3 months postoperative
Secondary Functional factors: leg strength and endurance Measured with 30 seconds Timed Chair-Stand-Test 1 year postoperative
Secondary Patient demographics measured with Knee Society Scoring System (KSS): subscale patient demographics (nominal) Baseline (preoperative)
Secondary Alignment measured with Knee Society Scoring System (KSS): subscale objective knee score 'alignment': weight-bearing anterior-posterior radiograph measuring the femoral-tibial (Anatomic) axis. Minimum is 0, maximum is 25. The higher the score, the better the alignment. Baseline (preoperative)
Secondary Instability measured with Knee Society Scoring System (KSS): subscale objective knee score 'instability'. Minimum is 0, maximum is 25. The higher the score, the better the stability. Baseline (preoperative)
Secondary Joint motion measured with Knee Society Scoring System (KSS): subscale objective knee score 'joint motion'. Minimum is 0, maximum can be higher than 25. One point for every joint motion of 5 degrees. The higher the score, the better the joint motion. Baseline (preoperative)
Secondary Pain symptoms measured with Knee Society Scoring System (KSS): subscale symptoms. Minimum score is 0, maximum score is 25. The higher the score, the worse the pain symptoms. Change from baseline (preoperative) to 3 months postoperative
Secondary Pain symptoms measured with Knee Society Scoring System (KSS): subscale symptoms. Minimum score is 0, maximum score is 25. The higher the score, the worse the pain symptoms. Change from baseline (preoperative) to 1 year postoperative
Secondary Pain symptoms measured with Knee Society Scoring System (KSS): subscale symptoms. Minimum score is 0, maximum score is 25. The higher the score, the worse the pain symptoms. Change from 3 months postoperative to 1 year postoperative
Secondary Pain symptoms measured with Knee Society Scoring System (KSS): subscale symptoms. Minimum score is 0, maximum score is 25. The higher the score, the worse the pain symptoms. Baseline (preoperative)
Secondary Pain symptoms measured with Knee Society Scoring System (KSS): subscale symptoms. Minimum score is 0, maximum score is 25. The higher the score, the worse the pain symptoms. 3 months postoperative
Secondary Pain symptoms measured with Knee Society Scoring System (KSS): subscale symptoms. Minimum score is 0, maximum score is 25. The higher the score, the worse the pain symptoms. 1 year postoperative
Secondary Patient expectations measured with Knee Society Scoring System (KSS): subscale patient expectations. Minimum score is 0, maximum score is 15. The higher the score, the higher the patient's opinion on the extent to which the patient expects that the operation will improve their knee pain, and their ability to perform their activities of daily living and recreational activities Baseline (preoperative)
Secondary Patient expectations fulfillment measured with Knee Society Scoring System (KSS): subscale patient expectations. Minimum score is 0, maximum score is 15. The higher the score, the higher the patient's opinion on the extent to which the outcome after the operation has met the patient's pre-operative expectations with respect to pain and function 3 months postoperative
Secondary Patient expectations fulfillment measured with Knee Society Scoring System (KSS): subscale patient expectations. Minimum score is 0, maximum score is 15. The higher the score, the higher the patient's opinion on the extent to which the outcome after the operation has met the patient's pre-operative expectations with respect to pain and function 1 year postoperative
Secondary Patient expectations fulfillment measured with Knee Society Scoring System (KSS): subscale patient expectations. Minimum score is 0, maximum score is 15. The higher the score, the higher the patient's opinion on the extent to which the outcome after the operation has met the patient's pre-operative expectations with respect to pain and function Change from 3 months postoperative to 1 year postoperative
Secondary Patient satisfaction measured with Knee Society Scoring System (KSS): subscale patient satisfaction. Minimum score is 0, maximum score is 40. The higher the score, the more satisfied the patient feels with their knee. Change from baseline (preoperative) to 3 months postoperative
Secondary Patient satisfaction measured with Knee Society Scoring System (KSS): subscale patient satisfaction. Minimum score is 0, maximum score is 40. The higher the score, the more satisfied the patient feels with their knee. Change from baseline (preoperative) to 1 year postoperative
Secondary Patient satisfaction measured with Knee Society Scoring System (KSS): subscale patient satisfaction. Minimum score is 0, maximum score is 40. The higher the score, the more satisfied the patient feels with their knee. Change from 3 months postoperative to 1 year postoperative
Secondary Patient satisfaction measured with Knee Society Scoring System (KSS): subscale patient satisfaction. Minimum score is 0, maximum score is 40. The higher the score, the more satisfied the patient feels with their knee. Baseline (preoperative)
Secondary Patient satisfaction measured with Knee Society Scoring System (KSS): subscale patient satisfaction. Minimum score is 0, maximum score is 40. The higher the score, the more satisfied the patient feels with their knee. 3 months postoperative
Secondary Patient satisfaction measured with Knee Society Scoring System (KSS): subscale patient satisfaction. Minimum score is 0, maximum score is 40. The higher the score, the more satisfied the patient feels with their knee. 1 year postoperative
Secondary Functional score measured with Knee Society Scoring System (KSS): subscale functional score. Minimum score is 0, maximum score is 100. The higher the score, the better the functionality of the patient Change from baseline (preoperative) to 3 months postoperative
Secondary Functional score measured with Knee Society Scoring System (KSS): subscale functional score. Minimum score is 0, maximum score is 100. The higher the score, the better the functionality of the patient Change from baseline (preoperative) to 1 year postoperative
Secondary Functional score measured with Knee Society Scoring System (KSS): subscale functional score. Minimum score is 0, maximum score is 100. The higher the score, the better the functionality of the patient Change from 3 months postoperative to 1 year postoperative
Secondary Functional score measured with Knee Society Scoring System (KSS): subscale functional score. Minimum score is 0, maximum score is 100. The higher the score, the better the functionality of the patient Baseline (preoperative)
Secondary Functional score measured with Knee Society Scoring System (KSS): subscale functional score. Minimum score is 0, maximum score is 100. The higher the score, the better the functionality of the patient 3 months postoperative
Secondary Functional score measured with Knee Society Scoring System (KSS): subscale functional score. Minimum score is 0, maximum score is 100. The higher the score, the better the functionality of the patient 1 year postoperative
Secondary Metabolic factors: Fat mass Measured with Bio-electrical Impedance Analyses (BIA) Change from baseline (preoperative) to 3 months postoperative
Secondary Metabolic factors: Fat mass Measured with Bio-electrical Impedance Analyses (BIA) Change from baseline (preoperative) to 1 year postoperative
Secondary Metabolic factors: Fat mass Measured with Bio-electrical Impedance Analyses (BIA) Change from 3 months postoperative to 1 year postoperative
Secondary Metabolic factors: Fat mass Measured with Bio-electrical Impedance Analyses (BIA) Baseline (preoperative)
Secondary Metabolic factors: Fat mass Measured with Bio-electrical Impedance Analyses (BIA) 3 months postoperative
Secondary Metabolic factors: Fat mass Measured with Bio-electrical Impedance Analyses (BIA) 1 year postoperative
Secondary Metabolic factors: Lean mass Measured with Bio-electrical Impedance Analyses (BIA) Change from baseline (preoperative) to 3 months postoperative
Secondary Metabolic factors: Lean mass Measured with Bio-electrical Impedance Analyses (BIA) Change from baseline (preoperative) to 1 year postoperative
Secondary Metabolic factors: Lean mass Measured with Bio-electrical Impedance Analyses (BIA) Change from 3 months postoperative to 1 year postoperative
Secondary Metabolic factors: Lean mass Measured with Bio-electrical Impedance Analyses (BIA) Baseline (preoperative)
Secondary Metabolic factors: Lean mass Measured with Bio-electrical Impedance Analyses (BIA) 3 months postoperative
Secondary Metabolic factors: Lean mass Measured with Bio-electrical Impedance Analyses (BIA) 1 year postoperative
Secondary Metabolic factors: Body mass index (BMI) Measured with length of patient (cm) and weight of patient (kg) Change from baseline (preoperative) to 3 months postoperative
Secondary Metabolic factors: Body mass index (BMI) Measured with length of patient (cm) and weight of patient (kg) Change from baseline (preoperative) to 1 year postoperative
Secondary Metabolic factors: Body mass index (BMI) Measured with length of patient (cm) and weight of patient (kg) Change from 3 months postoperative to 1 year postoperative
Secondary Metabolic factors: Body mass index (BMI) Measured with length of patient (cm) and weight of patient (kg) Baseline (preoperative)
Secondary Metabolic factors: Body mass index (BMI) Measured with length of patient (cm) and weight of patient (kg) 3 months postoperative
Secondary Metabolic factors: Body mass index (BMI) Measured with length of patient (cm) and weight of patient (kg) 1 year postoperative
Secondary Metabolic factors: body composition Measured with Bioelectrical Impedance Analysis (BIA) Baseline (preoperative), 3 months postoperative, 1 year postoperative.
Secondary Metabolic factors: venous blood sample Measured with A1C test or glycohemoglobin test Change from baseline (preoperative) to 3 months postoperative
Secondary Metabolic factors: venous blood sample Measured with A1C test or glycohemoglobin test Change from baseline (preoperative) to 1 year postoperative
Secondary Metabolic factors: venous blood sample Measured with A1C test or glycohemoglobin test Change from 3 months postoperative to 1 year postoperative
Secondary Metabolic factors: venous blood sample Measured with A1C test or glycohemoglobin test Baseline (preoperative)
Secondary Metabolic factors: venous blood sample Measured with A1C test or glycohemoglobin test 3 months postoperative
Secondary Metabolic factors: venous blood sample Measured with A1C test or glycohemoglobin test 1 year postoperative.
Secondary Structural factors Measured with Kellgren and Lawrence scale on radiography Baseline (preoperative)
Secondary Inflammatory factors: signs of inflammation Measured with the C-reactive protein levels in blood sample (collected from patient record) Baseline (preoperative)
Secondary Anesthetic procedure General anesthesia, spinal anesthesia or combination with peripheral block During surgery
Secondary Clinical pain score Measured with numeric rating pain scale day 1 and 2 postoperative
See also
  Status Clinical Trial Phase
Recruiting NCT03895489 - Effectiveness of the Journey Total Knee Arthroplasty Versus Two Standard of Care Total Knee Arthroplasty Prostheses N/A
Completed NCT03660943 - A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain Phase 3
Completed NCT04531969 - Comparison of Outpatient and Inpatient Spa Therapy N/A
Completed NCT02848027 - Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx®SD Treatment Phase 3
Completed NCT05160246 - The Instant Effect of Kinesiology Taping in Patients With Knee OA N/A
Recruiting NCT06080763 - Biomechanics and Clinical Outcomes in Responders and Non-Responders
Completed NCT03643588 - The Comparison of HYAJOINT Plus and Hyalgan Hyaluronan Supplement for Knee Osteoarthritis Pain N/A
Active, not recruiting NCT05100225 - Efficacy and Safety Trial of PTP-001 (MOTYS) for Symptomatic Knee Osteoarthritis Phase 2
Active, not recruiting NCT04061733 - New Hydroxyethyl Cellulose Hydrogel for the Treatment of the Pain of Knee Arthrosis N/A
Completed NCT04051489 - A Novel Smartphone Application for "Smart" Knee Osteoarthritis Trials
Recruiting NCT05546541 - Epidemiology and Nutrition
Recruiting NCT05447767 - Prediction AlgoriThm for regeneraTive Medicine Approach in knEe OA: New Decision-making Process Based on Patient pRofiliNg Phase 2
Not yet recruiting NCT04448106 - Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis Phase 2
Not yet recruiting NCT03225911 - Effect of a Lateral Wedge Insole and Simple Knee Sleeve in Individuals With Knee Osteoarthritis N/A
Completed NCT05070871 - A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women N/A
Completed NCT05703087 - Positive Cueing in Knee Arthroplasty. N/A
Not yet recruiting NCT06042426 - Effects of Perioperative Intravenous Dexamethasone in Clinical Outcomes After Total Knee Arthroplasty in a Hispanic Population Phase 4
Terminated NCT02909257 - Motor-Sparing Femoral Nerve Block Dose Phase 4
Terminated NCT02615522 - Prospective Post Market Clinical Follow-Up of the Primary Knee Endoprosthesis BPK-S Integration
Completed NCT02881775 - Immediate Effects of rTMS on Excitability of the Quadriceps With Knee Osteoarthritis N/A